News

For colon cancer that no longer responds to treatment, a new drug combination offers hope
A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...
Fierce Pharma1d
Sanofi and Regeneron's high-flying Dupixent on course for an 'inflection year' in COPD
As Sanofi anticipates sales of immunotherapy juggernaut Dupixent reaching a major $22 billion by the end of the decade, ...
Becker's Hospital Review1d
Are We Missing Opportunities to Help Patients? With Severe Emphysema, the Answer is Yes
Advanced Treatments Create New Prospects for Patients and Their Healthcare Providers New FDA-approved medical treatments can be transformative for patients and families, often providing them with more ...
Pharmaceutical Technology2d
TNF and Renova Health use AI to identify patients for GLP-1 treatments
TNF and Renova Health are set to use AI and ML for the identification of high-risk subjects who could benefit from GLP-1 ...
Science Daily2d
Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease, study suggests
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
Pulmonology Advisor4d
Major Adverse Cardiac Events More Common in COPD With CVD vs CVD Alone
Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.